Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

HUMAW

Humacyte, Inc.

CIK 0001818382 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.01
↓ 0.00 (-43.33%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$1.13M
P/E Ratio
-0.01
EPS
-0.26
Dividend Yield
Not covered
52W Position
1%
Beta
0.47

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.10
P/S
0.56
EV/Revenue
-5.72
ROE
-839.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$0.00$0.40

Latest Financials

2025-12-31 FY
Revenue
$2.04M
Net Income
-$40.83M
Total Assets
$116.37M
Free Cash Flow
-$105.93M

Recent news